HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
37.330 |
Evidence |
O
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
GRB14 |
GRB14: Growth factor receptor-bound protein 14 |
37.120 |
Evidence |
O
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
37.120 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
GRB14 |
GRB14: Growth factor receptor-bound protein 14 |
37.120 |
Evidence |
|
PLG |
PLG: Plasminogen precursor |
HRG |
HRG: Histidine-rich glycoprotein precursor |
36.740 |
Evidence |
O
|
MET |
MET: Hepatocyte growth factor receptor precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
36.670 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
36.660 |
Evidence |
|
NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
CREBBP |
CREBBP, CBP: CREB-binding protein |
36.660 |
Evidence |
|
IRF3 |
IRF3: Interferon regulatory factor 3 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
36.660 |
Evidence |
O
|
CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
CHRNB4 |
CHRNB4: Neuronal acetylcholine receptor subunit beta-4 precursor |
36.640 |
Evidence |
O
|
TCF4 |
TCF4, ITF2, SEF2: Transcription factor 4 |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
36.640 |
Evidence |
|
ID4 |
ID4: DNA-binding protein inhibitor ID-4 |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
36.640 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BAK1 |
IPI00003352 |
36.640 |
Evidence |
|
KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
KCNJ3 |
KCNJ3, GIRK1: G protein-activated inward rectifier potassium channel 1 |
36.640 |
Evidence |
O
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
36.320 |
Evidence |
|
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
36.320 |
Evidence |
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
36.060 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
CREBBP |
CREBBP, CBP: CREB-binding protein |
35.9 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
F7 |
F7: Coagulation factor VII precursor |
35.750 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
F7 |
F7: Coagulation factor VII precursor |
35.750 |
Evidence |
|
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
CFL1 |
CFL1, CFL: Cofilin-1 |
35.680 |
Evidence |
O
|
NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
35.460 |
Evidence |
|
SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
35.140 |
Evidence |
|
CDK2 |
CDK2: Cell division protein kinase 2 |
NPM1 |
NPM1, NPM: Nucleophosmin |
35.060 |
Evidence |
|
HDAC3 |
HDAC3: Histone deacetylase 3 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
35.060 |
Evidence |
|